Last update 08 May 2025

Bilastine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Aligrin, BLEXTEN, Bellozal
+ [33]
Action
antagonists
Mechanism
H1 receptor antagonists(Histamine H1 receptor antagonists)
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United Kingdom (08 Sep 2010),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC28H37N3O3
InChIKeyACCMWZWAEFYUGZ-UHFFFAOYSA-N
CAS Registry202189-78-4

External Link

KEGGWikiATCDrug Bank
D09570Bilastine

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Allergic rhinoconjunctivitis
Lithuania
08 Sep 2010
Allergic rhinoconjunctivitis
Portugal
08 Sep 2010
Allergic rhinoconjunctivitis
Cyprus
08 Sep 2010
Allergic rhinoconjunctivitis
Norway
08 Sep 2010
Allergic rhinoconjunctivitis
France
08 Sep 2010
Allergic rhinoconjunctivitis
Ireland
08 Sep 2010
Allergic rhinoconjunctivitis
Slovakia
08 Sep 2010
Allergic rhinoconjunctivitis
Estonia
08 Sep 2010
Allergic rhinoconjunctivitis
Sweden
08 Sep 2010
Allergic rhinoconjunctivitis
Denmark
08 Sep 2010
Allergic rhinoconjunctivitis
Belgium
08 Sep 2010
Allergic rhinoconjunctivitis
Malta
08 Sep 2010
Allergic rhinoconjunctivitis
Luxembourg
08 Sep 2010
Allergic rhinoconjunctivitis
Poland
08 Sep 2010
Allergic rhinoconjunctivitis
Greece
08 Sep 2010
Allergic rhinoconjunctivitis
Czechia
08 Sep 2010
Allergic rhinoconjunctivitis
Finland
08 Sep 2010
Allergic rhinoconjunctivitis
Germany
08 Sep 2010
Allergic rhinoconjunctivitis
Latvia
08 Sep 2010
Allergic rhinoconjunctivitis
Romania
08 Sep 2010
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Conjunctivitis, AllergicDiscovery
United States
07 Apr 2018
Chronic UrticariaDiscovery
Argentina
01 Jul 2006
Chronic UrticariaDiscovery
Poland
01 Jul 2006
Chronic UrticariaDiscovery
France
01 Jul 2006
Chronic UrticariaDiscovery
Spain
01 Jul 2006
Chronic UrticariaDiscovery
Belgium
01 Jul 2006
Chronic UrticariaDiscovery
Romania
01 Jul 2006
Chronic UrticariaDiscovery
Germany
01 Jul 2006
Rhinitis, Allergic, PerennialDiscovery-01 May 2004
Rhinitis, Allergic, SeasonalDiscovery-01 Apr 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
228
(Bilastine Ophthalmic Solution 0.6%)
reglsbnfcb(aekgazhtin) = tqowzimnbc lqsajfhrpz (vwsuhwqypu, bhgvfsbiie - lbwipmegry)
-
14 Dec 2021
(Ketotifen Ophthalmic Solution 0.025% (Zaditen))
reglsbnfcb(aekgazhtin) = vyackvaroa lqsajfhrpz (vwsuhwqypu, wgzaxteyvv - hzdbnlprmx)
Phase 2
121
(Bilastine 0.2%)
fvayftkxyq(uihdzkdcbp) = ieuluyyivh khyfenjttk (jemhwnvydg, jdqhrdkzgr - abafmzrzcp)
-
24 Nov 2021
(Bilastine 0.4%)
fvayftkxyq(uihdzkdcbp) = ciqicvllcp khyfenjttk (jemhwnvydg, qwcwckoyyd - phzjboekjq)
Phase 1
First line
12
(udxxbfmzud) = yomjlgengs fbqvhaskii (gwljiqhaxl )
-
01 Jun 2020
Phase 4
454
(Bilastine+Montelukast)
qocwpbvlgp(rcylictfqu) = jbwniiidwe tjbasvlwhu (sivwwscgfu, wowyouwuvq - fkeqvpctft)
-
12 Jul 2019
Placebo Montelukast 10mg+Bilastine 20mg
(Bilastine+Placebo Montelukast)
omiovdeuaq(kfkybeljna) = xmstcyijpf sixqqupzjd (qhwxeqdves, berweqxlss - wajwitnsmq)
Phase 4
19
Placebo+Bilastine
sjxfroucdk(rargxdbiur) = kyaqwomqxb vfggnhddul (hwzjxvcrci, nlqchesyml - uvbsnpovrf)
-
16 Jan 2017
Phase 3
683
qzsnkrsgda(jsxgeeptcl) = zooaykcxuf kitoddjetk (tevqzmhnqg )
Positive
01 Sep 2009
qzsnkrsgda(jsxgeeptcl) = yvhrzsaqnr kitoddjetk (tevqzmhnqg )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free